These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19871093)

  • 1. THE EFFECT OF A POLYSACCHARIDE-SPLITTING ENZYME ON STREPTOCOCCAL INFECTION.
    Hirst GK
    J Exp Med; 1941 Mar; 73(4):493-506. PubMed ID: 19871093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of hyaluronidase and type-specific anti-M serum on experimental group A streptococcus infection in mice.
    ROTHBARD S
    J Exp Med; 1948 Sep; 88(3):325-42. PubMed ID: 18881491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the virulence of group A streptococci: evidence for virulence factors other than M-protein and capsule.
    Becker CG; Resnick GD; Shustak S
    Am J Pathol; 1973 Jul; 72(1):129-36. PubMed ID: 4719525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Conserved Streptococcal Virulence Regulator Controls the Expression of a Distinct Class of M-Like Proteins.
    D'Gama JD; Ma Z; Zhang H; Liu X; Fan H; Morris ERA; Cohen ND; Cywes-Bentley C; Pier GB; Waldor MK
    mBio; 2019 Oct; 10(5):. PubMed ID: 31641092
    [No Abstract]   [Full Text] [Related]  

  • 5. THE ROLE OF THE MUCOID POLYSACCHARIDE (HYALURONIC ACID) IN THE VIRULENCE OF GROUP A HEMOLYTIC STREPTOCOCCI.
    Kass EH; Seastone CV
    J Exp Med; 1944 Mar; 79(3):319-30. PubMed ID: 19871373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the pathogenicity of group A streptococci. II. The antiphagocytic effects of the M protein and the capsular gel.
    FOLEY MJ; WOOD WB
    J Exp Med; 1959 Oct; 110(4):617-28. PubMed ID: 13823728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of a cysteine protease effect on bacterial virulence in two murine models of human invasive group A streptococcal infection.
    Ashbaugh CD; Wessels MR
    Infect Immun; 2001 Nov; 69(11):6683-8. PubMed ID: 11598038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TISSUE CULTURE STUDIES ON BACTERIAL HYPERSENSITIVITY : II. REACTIONS OF TISSUES FROM GUINEA PIGS INFECTED WITH GROUP C HEMOLYTIC STREPTOCOCCI.
    Moen JK
    J Exp Med; 1936 Aug; 64(3):355-68. PubMed ID: 19870540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HYALURONIDASES OF BACTERIAL AND ANIMAL ORIGIN.
    Meyer K; Chaffee E; Hobby GL; Dawson MH
    J Exp Med; 1941 Feb; 73(3):309-26. PubMed ID: 19871080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. THE HYDROLYSIS OF HYALURONIC ACID BY BACTERIAL ENZYMES.
    Meyer K; Hobby GL; Chaffee E; Dawson MH
    J Exp Med; 1940 Jan; 71(2):137-46. PubMed ID: 19870951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical role of the group A streptococcal capsule in pharyngeal colonization and infection in mice.
    Wessels MR; Bronze MS
    Proc Natl Acad Sci U S A; 1994 Dec; 91(25):12238-42. PubMed ID: 7991612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TISSUE CULTURE STUDIES ON BACTERIAL HYPERSENSITIVITY : IV. PROTECTIVE EFFECT OF IMMUNE PLASMA AGAINST THE DELETERIOUS INFLUENCE OF STREPTOCOCCAL EXTRACT ON HYPERSENSITIVE CELLS.
    Moen JK
    J Exp Med; 1937 Mar; 65(4):587-94. PubMed ID: 19870620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci.
    Marques MB; Kasper DL; Pangburn MK; Wessels MR
    Infect Immun; 1992 Oct; 60(10):3986-93. PubMed ID: 1398910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. THE OCCURRENCE OF MUCOID POLYSACCHARIDE IN HEMOLYTIC STREPTOCOCCI OF HUMAN ORIGIN.
    Seastone CV
    J Exp Med; 1943 Jan; 77(1):21-8. PubMed ID: 19871261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low rates of streptococcal pharyngitis and high rates of pyoderma in Australian aboriginal communities where acute rheumatic fever is hyperendemic.
    McDonald MI; Towers RJ; Andrews RM; Benger N; Currie BJ; Carapetis JR
    Clin Infect Dis; 2006 Sep; 43(6):683-9. PubMed ID: 16912939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation occurring in group A streptococci during human infection; progressive loss of M substance correlated with increasing susceptibility to bacteriostasis.
    ROTHBARD S; WATSON RF
    J Exp Med; 1948 Jun; 87(6):521-33. PubMed ID: 18858642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The pharyngeal beta-hemolytic streptococcal carrier state among blood donors].
    Briko NI; Eshchina AS; Shikhman AR; Serna FR; Kondrakova OA; Smirnova MN; Dynga LO; Zhukov VV
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jan; (1):24-7. PubMed ID: 1858466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virulence properties of type VII Streptococcus agalactiae (group B streptococci) and immunochemical analysis of capsular type polysaccharide.
    VON Hunolstein C; Parisi L; Tissi L; Recchia S; Alfarone G; Nicolini L; Volpe C; Wagner B; Motlova J; Orefici G
    J Med Microbiol; 1999 Nov; 48(11):983-990. PubMed ID: 10535641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing trends in β-hemolytic streptococcal bacteremia in Manitoba, Canada: 2007-2012.
    Schwartz IS; Keynan Y; Gilmour MW; Dufault B; Lagacé-Wiens P
    Int J Infect Dis; 2014 Nov; 28():211-3. PubMed ID: 25403914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STUDIES ON THE HEMOLYTIC STREPTOCOCCUS OF HUMAN ORIGIN : II. OBSERVATIONS ON THE PROTECTIVE MECHANISM AGAINST THE VIRULENT VARIANTS.
    Lyons C; Ward HK
    J Exp Med; 1935 Mar; 61(4):531-43. PubMed ID: 19870377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.